Dr Reddy's Laboratories plans capacity expansion by 2013

Hyderabad: Dr Reddy's Laboratories (DRL) plans investments worth around Rs 1,600 crore over the next two years for capacity expansion and building new capabilities by 2013.

The will be investing Rs 150 crore in the biologics segment and $150 million (over Rs 700 crore) every year for the next two years in global generics and pharmaceutical services and active ingredients (PSAI).